BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38529202)

  • 1. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis.
    Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
    Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
    Peng F; Li H; You Q; Li H; Wu D; Jiang C; Deng G; Li Y; Li Y; Wu Y
    Biomed Res Int; 2017; 2017():5019367. PubMed ID: 28386553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
    Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.
    Xie Z; Hao Q; Zhu R; Ma R
    Can J Gastroenterol Hepatol; 2024; 2024():2211179. PubMed ID: 38529202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
    Yan SR; Liu ZJ; Yu S; Bao YX
    Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
    Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
    Zhang Y; Li Y; Jiang W; Li Q; Lan Y
    Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Huang X; Xiong Y; Yang J; Yang G; Li J
    Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients' Survival.
    Ali DA; Sabry NM; Kabel AM; Gaber RA; Mokhtar HM; Samy SM; Elrashidy MA; Salama SA; Abdelhai D
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577789
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma.
    Chen S; Fu Z; Wen S; Yang X; Yu C; Zhou W; Lin Y; Lv Y
    Front Genet; 2021; 12():666306. PubMed ID: 34163524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment.
    Leone P; Solimando AG; Fasano R; Argentiero A; Malerba E; Buonavoglia A; Lupo LG; De Re V; Silvestris N; Racanelli V
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34065489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA in cancer.
    Goodall GJ; Wickramasinghe VO
    Nat Rev Cancer; 2021 Jan; 21(1):22-36. PubMed ID: 33082563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-15/107 microRNA Gene Group: Characteristics and Functional Implications in Cancer.
    Turco C; Donzelli S; Fontemaggi G
    Front Cell Dev Biol; 2020; 8():427. PubMed ID: 32626702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis.
    Zhao B; Wang Y; Tan X; Ke K; Zheng X; Wang F; Lan S; Liao N; Cai Z; Shi Y; Zheng Y; Lai Y; Wang L; Li Q; Liu J; Huang A; Liu X
    Mol Ther Oncolytics; 2019 Dec; 15():79-90. PubMed ID: 31650028
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.